moxifloxacin
UkraineDrugs containing this active substance
-
The drug is prescribed for the treatment of acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs of mild to moderate severity in adults.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: KUSUM FARM LLC
-
The drug is used to treat bacterial infections in adults (from 18 years of age), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
-
The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues. It should be used only when other antibacterial agents recommended for initial treatment are inappropriate.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: Bayer AG (batch release)
-
The drug is used to treat non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: Vioser S.A. Parenteral Solutions Industries (unpacked product, primary packaging, secondary packaging, control)
-
The drug is used for the topical treatment of bacterial conjunctivitis caused by bacteria sensitive to it.
Form: drops, ophthalmic
Active substance Dosage moxifloxacin 5 mg/ml ATC: S01AE07
Manufacturer: Farmak JSC
-
The drug is used to treat non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: JSC "Farmak" (full production cycle)
-
The drug is prescribed for the treatment of bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic bronchitis, non-hospital pneumonia, and moderate to severe inflammatory diseases of the pelvic organs.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: Sunshine Lake Pharma Co., Ltd.
-
The drug is intended for the treatment of community-acquired pneumonia, as well as complicated skin and soft tissue infections.
Form: concentrate for infusion solution
Active substance Dosage moxifloxacin 20 mg/ml ATC: J01MA14
Manufacturer: Yuria-Pharm LLC
-
The drug is indicated for the treatment of non-hospital pneumonia, as well as complicated infections of the skin and soft tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 1.6 mg/ml ATC: J01MA14
Manufacturer: Yuria-Pharm LLC
-
The drug is used to treat non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: ANFARM HELLAS S.A.
-
The drug is prescribed for the treatment of bacterial infections, including acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs (under certain conditions).
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
-
The drug is used for the treatment of community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 1.6 mg/ml ATC: J01MA14
-
The drug is prescribed for the treatment of bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic bronchitis, non-hospital pneumonia, and inflammatory diseases of the pelvic organs.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: Torrent Pharmaceuticals Ltd
-
The drug is used for the local treatment of bacterial conjunctivitis caused by bacterial strains sensitive to it.
Form: drops, ophthalmic solution
Active substance Dosage moxifloxacin 5 mg/ml ATC: S01AE07
-
The drug is used for the local treatment of bacterial conjunctivitis caused by bacteria sensitive to it.
Form: drops, ophthalmic solution
Active substance Dosage moxifloxacin 5 mg/ml ATC: S01AE07
Manufacturer: Jadran-Galenski Laboratorij d.d.
-
The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: ANFARM HELLAS S.A.
-
The drug is used for the local treatment of bacterial conjunctivitis caused by bacteria sensitive to it.
Form: drops, ophthalmic
Active substance Dosage moxifloxacin 5 mg/ml ATC: S01AE07
Manufacturer: Indoco Remedies Limited
-
The drug is used to treat bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: Hetero Labs Limited
-
The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: PJSC "Infuziya"
-
The drug is prescribed for the treatment of bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and mild to moderate pelvic inflammatory diseases.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: PJSC "Tekhnolog"
-
The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: Subsidiary Enterprise "Farmatreyd"
-
The drug is prescribed for the treatment of bacterial infections, including acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, moderate to severe pelvic inflammatory diseases, as well as complicated skin and subcutaneous tissue infections.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is used to treat non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: PJSC "Halychpharm"
-
The drug is used to treat bacterial infections, including acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), community-acquired pneumonia, and mild to moderate pelvic inflammatory diseases. It can also be used to complete a course of treatment after intravenous administration for community-acquired pneumonia or complicated skin infections.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: ASTRAFARM LLC
-
The drug is prescribed to adults for the treatment of bacterial infections, including acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs. It can also be used to complete a course of treatment following intravenous injections for pneumonia or complicated skin infections.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: JSC "Lubnipharm"
-
The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: VEM Ilac San. ve Tik. A.S.
-
The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and skin appendages.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is prescribed for the treatment of bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: Farmex Group LLC
-
The drug is used for the topical treatment of bacterial conjunctivitis caused by bacterial strains sensitive to it.
Form: drops, ophthalmic
Active substance Dosage moxifloxacin 5 mg/ml ATC: S01AE07
Manufacturer: Farmex Group LLC
-
The drug is prescribed for the treatment of non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: JSC FARMATEN
-
The drug is used to treat bacterial infections in adults (from 18 years of age), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), community-acquired pneumonia, and inflammatory diseases of the pelvic organs.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.
-
The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: Subsidiary Enterprise "Farmatreyd"
-
The drug is prescribed for the treatment of bacterial infections in adults (from 18 years of age), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and moderate to severe inflammatory diseases of the pelvic organs.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used to treat bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic bronchitis, non-hospital pneumonia, and mild to moderate pelvic inflammatory diseases.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: Bafna Pharmaceuticals Ltd.
-
The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.
Form: solution for infusion
Active substance Dosage moxifloxacin 400 mg/250 ml ATC: J01MA14
Manufacturer: Evrolife Healthcare Pvt. Ltd.
-
The drug is used to treat bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: Aurobindo Pharma Limited – Unit VII
-
The drug is used for the topical treatment of bacterial conjunctivitis caused by bacteria sensitive to it.
Form: drops, ophthalmic
Active substance Dosage moxifloxacin 5 mg/ml ATC: S01AE07
Manufacturer: Farmaten S.A. (secondary packaging, quality control and batch release)
-
The drug is prescribed for the treatment of bacterial infections in adults (from 18 years old), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and moderate to severe inflammatory diseases of the pelvic organs.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: ALKALOID AD Skopje
-
The drug is used to treat bacterial infections in adults (from 18 years old), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.
Form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
Manufacturer: Rivopharm SA
-
The drug is used for the topical treatment of bacterial conjunctivitis caused by bacteria sensitive to it.
Form: drops, ophthalmic
Active substance Dosage moxifloxacin 5 mg/ml ATC: S01AE07
Manufacturer: Alcon Coutier